A USABILITY STUDY ASSESSING HANDLING AND PREFERENCE OF THE CONCIZUMAB PEN-INJECTOR IN PATIENTS WITH HAEMOPHILIA AND CAREGIVERS
Introduction: Concizumab is a once-daily prophylactic treatment in development for haemophilia A or B with or without inhibitors, and it is potentially the first treatment for haemophilia patients to be delivered subcutaneously using a prefilled, multi-dose pen-injector with a 4 mm, 32 G needle. Aim...
Main Authors: | NK Rasmussen, B Berg, JS Neergaard, S Shah, G Ter-Borch, T Sparre, GG Fabbron |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Hematology, Transfusion and Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137923010283 |
Similar Items
-
TREATMENT BURDEN AND PATIENT PREFERENCE IN PATIENTS WITH HEMOPHILIA A OR B WITH INHIBITORS ON CONCIZUMAB PROPHYLAXIS: RESULTS FROM THE PHASE 3 EXPLORER7 STUDY
by: K Hampton, et al.
Published: (2023-10-01) -
HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH HEMOPHILIA A OR B WITH INHIBITORS ON CONCIZUMAB PROPHYLAXIS: RESULTS FROM THE PHASE 3 EXPLORER7 STUDY
by: AD Shapiro, et al.
Published: (2023-10-01) -
Comparative evaluation and preference of MixPro® versus Mix2Vial® reconstitution devices among people with haemophilia and caregivers
by: Hansen Jon Ulrich, et al.
Published: (2022-10-01) -
Usability of the Stylus Pen in Mobile Electronic Documentation
by: Eunil Park, et al.
Published: (2015-11-01) -
Haemophilia specialist nurses’ perceptions of haemophilia B
by: Chaplin Steve, et al.
Published: (2021-10-01)